S. Harwix et al., T-cell clones from early-stage cutaneous T-cell lymphoma show no polarizedTh-1 or Th-2 cytokine profile, ARCH DERM R, 292(1), 2000, pp. 1-8
Recent studies of the cytokine pattern in skin lesions of patients with cut
aneous T-cell lymphoma (CTCL) have shown that interleukin-4 (IL-4) and Il-1
0, both cytokines produced by T-helper type 2 cells, dominate in these lesi
ons. Also, in single studies, interferon-gamma (IFN-gamma), a major cytokin
e of Th-1-cells, has been found to be absent. Consequently, it has been hyp
othesized that immune-suppressive Th-2 cytokines may promote local growth o
f the malignant lymphocyte clone. However, there is so far no evidence for
T-cells as the source of the Th-2 cytokines in CTCL skin lesions nor have t
hese cytokines been investigated at a clonal T-cell level. We established a
total of 120 T-cell clones (TCCs) from lesional skin and 54 TCCs from the
blood of four patients with mycosis fungoides. Epidermal TCCs (mostly CD8-p
ositive) and dermal TCCs (mostly CD4-positive) were stimulated by the mitog
en concanavalin A and, seeking a polarized cytokine pattern, the supernatan
ts were assessed by ELISA. We showed that the vast majority of TCCs were ab
le to secrete IFN-gamma and IL-4. IFN-gamma-deficient TCCs occurred only in
the epidermis. Some (18) TCCs were found to be either negative for IL-10 p
roduction or to produce low levels only. No significant differences were ob
served between blood- and skin-derived TCCs. Thus a polarized Th-2 cytokine
pattern was not detectable among cultured skin-infiltrating nonmalignant T
-cells (TILs) isolated from early mycosis fungoides. It therefore appears u
nlikely that Th-2-mediated immune suppression is a major mechanism operatin
g in early CTCL. However, this does not exclude its role in late-stage dise
ase.